Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

[1]  RobertI Miller,et al.  Clinical Outcomes and Dosimetric Considerations Using Stereotactic Body Radiotherapy for Abdominopelvic Tumors , 2012, American journal of clinical oncology.

[2]  Jianmin Tian,et al.  Photodynamic Therapy for Unresectable Cholangiocarcinoma , 2012, Digestive Diseases and Sciences.

[3]  P. Francescon,et al.  Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  P. Kim,et al.  Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. , 2011, AJR. American journal of roentgenology.

[5]  A. Koong,et al.  Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. , 2010, International journal of radiation oncology, biology, physics.

[6]  M. Schell,et al.  Stereotactic body radiation therapy: the report of AAPM Task Group 101. , 2010, Medical physics.

[7]  R. T. Ten Haken,et al.  Radiation-associated liver injury. , 2010, International journal of radiation oncology, biology, physics.

[8]  M. Høyer,et al.  Stereotactic body radiotherapy for unresectable cholangiocarcinoma. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[10]  K. Sung,et al.  Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma , 2008, Cancer.

[11]  Maria Hawkins,et al.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Sorrell,et al.  Hepatic complications of hematopoietic cell transplantation , 2007, Current gastroenterology reports.

[13]  F. Giuliante,et al.  Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results. , 2006, International journal of radiation oncology, biology, physics.

[14]  R. T. Ten Haken,et al.  Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  G. Gores,et al.  Liver Transplantation with Neoadjuvant Chemoradiation is More Effective than Resection for Hilar Cholangiocarcinoma , 2005, Annals of surgery.

[16]  H. El‐Serag,et al.  The epidemiology of cholangiocarcinoma. , 2004, Seminars in liver disease.

[17]  U. Mansmann,et al.  Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. , 2003, Gastroenterology.

[18]  M. D'Angelica,et al.  Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma , 2003, Cancer.

[19]  S. Curley,et al.  Limitations of conventional doses of chemoradiation for unresectable biliary cancer. , 2002, International journal of radiation oncology, biology, physics.

[20]  M. Gonen,et al.  Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma , 2001, Annals of surgery.

[21]  F. Lohr,et al.  Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Mohiuddin,et al.  The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. , 1994, International journal of radiation oncology, biology, physics.